Skip to main content
. 2018 Nov 12;173(1):21–28. doi: 10.1001/jamapediatrics.2018.3407

Table 1. Child Demographic and Clinical Characteristics at Enrollment by Treatment Group.

Characteristic Children, No. (%)
Amoxicillin (n = 564) Placebo (n = 562) Overall (n = 1126)
Age, mo
2-11 196 (34.8) 196 (34.9) 392 (34.8)
12-35 255 (45.2) 254 (45.2) 509 (45.2)
36-59 113 (20.0) 112 (19.9) 225 (20.0)
Sex
Male 271 (48.0) 254 (45.2) 525 (46.6)
Female 293 (52.0) 308 (54.8) 601 (53.4)
Height/weight z scorea
<−3 0 1 (0.2) 1 (0.1)
−2 to −3 5 (0.9) 9 (1.6) 14 (1.2)
>−2 558 (98.9) 552 (98.2) 1110 (98.6)
Mid–upper arm circumference, cma
<11.5 0 0 0
11.5-13.5 32 (5.7) 45 (8.0) 77 (6.8)
>13.5 531 (94.1) 517 (92.0) 1048 (93.1)
Respiratory rate, mean (SD), breaths/minb
Age 2-11 mo
<50 1 (0.2) 0 1 (0.1)
50-59 133 (23.6) 146 (26.0) 279 (24.8)
≥60 62 (11.0) 50 (8.9) 112 (9.9)
Age 12-59 mo
<40 0 0 0
40-49 234 (41.5) 233 (41.5) 467 (41.5)
≥50 134 (23.8) 133 (23.7) 267 (23.7)
Oxygen saturation, %b
<90 0 0 0
90-92 0 0 0
≥93 564 (100) 562 (100) 1126 (100)
Axillary temperature, °Cb
<38 386 (68.4) 405 (72.1) 791 (70.2)
≥38 178 (31.6) 157 (27.9) 335 (29.8)
Heart rate, mean (SD), beats/mina 142.3 (18.1) 142.4 (17.2) 142.4 (17.6)
Pneumococcal vaccine
Received 3 doses 298 (52.8) 321 (57.1) 619 (55.0)
Received <3 doses or unknown 266 (47.2) 241 (42.9) 507 (45.0)
Pentavalent vaccine
Received 3 doses 301 (53.4) 319 (56.8) 620 (55.1)
Received <3 doses or unknown 263 (46.6) 243 (43.2) 506 (44.9)
Caregiver assessment at enrollment
Fevera
Yes 476 (84.4) 469 (83.5) 945 (83.9)
No. of days, mean (SD) 2.7 (1.1) 2.8 (1.4) 2.7 (1.2)
Cougha
Yes 546 (96.8) 547 (97.3) 1093 (97.1)
No. of days, mean (SD) 2.9 (1.2) 3.1 (1.5) 3.0 (1.4)
Difficult breathinga
Yes 180 (31.9) 180 (32.0) 360 (32.0)
No. of days, mean (SD) 2.5 (0.9) 2.6 (1.3) 2.5 (1.1)
a

Data not available for all randomized children.

b

Larger value between screening and enrollment visits.